ALYREF and breast cancer: As breast cancer is a heterogenous disease in terms of underlying biology, we analyzed different subtypes (by using the online tool bc-GenExMiner v4.7) and identified the highest ALYREF mRNA expression in the basal-like subtype (Fig. 1H, Table S3) and TNBC (Fig. S1B).